Skip to main content
ViatrisPatent grant

Viatris was granted a patent for meloxicam-based pain management.

What happened

In August 2026 Viatris patented a meloxicam treatment approach for managing acute, post-operative, and post-procedure pain in clinical care.

Source

Extracted by Autobound

From the Signal API record
Signal
Patent grant

What this signalsA new patent often shows where a company is putting its R&D budget.

Grant date
Aug 4, 2026
Inventors
4
Patent number
US12697341
Assignee
Viatris Inc.

The full record

From the Signal API record

People

  • Susanne VogtInventor
  • Jeffrey P. SmithInventor
  • Kathleen OcasioInventor
  • Joachim MausInventor
  • Kristina MarschallInventor
  • Matthew HummelInventor

Details

Primary CPC class
A61K 31/5415
USPTO assignee
Viatris Inc.
What the invention does
A method of using meloxicam to relieve pain after an operation or other medical procedure, as well as sudden acute pain.

Topics and mentions

Tags

  • Intellectual Property
  • Research & Development
  • Pharmaceuticals
  • Healthcare Technology

Technologies named

  • meloxicam
  • pain management
  • pharmaceutical treatment

Extraction

Detected
Sep 16, 2026
signal_type
patents-company
signal_subtype
patentGrant

Use this data

Get every patent signal for Viatris and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Viatris this week?”

  2. Send it to your own tools

    The Signal API returns patent signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full patents-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/2a9ab4e0-c8ed-535f-adcd-8e9b9d2f5b50 returns this record as JSON. POST /v1/companies/enrich returns every signal for viatris.com.

{
  "signal_id": "2a9ab4e0-c8ed-535f-adcd-8e9b9d2f5b50",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-09-16T05:42:42+00:00",
  "company": {
    "name": "Viatris",
    "domain": "viatris.com"
  },
  "data": {
    "cpc": [
      {
        "code": "A61K 31/5415"
      },
      {
        "code": "A61K 9/0053"
      },
      {
        "code": "A61K 9/2009"
      },
      {
        "code": "A61K 9/2027"
      },
      {
        "code": "A61K 9/2054"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Pharmaceuticals",
      "Healthcare Technology"
    ],
    "detail": "In August 2026 Viatris patented a meloxicam treatment approach for managing acute, post-operative, and post-procedure pain in clinical care.",
    "summary": "Viatris was granted a patent for meloxicam-based pain management.",
    "event_at": "2026-08-04",
    "inventors": [
      {
        "name": "Susanne Vogt",
        "status": "resolved",
        "is_primary": true,
        "linkedin_url": "https://www.linkedin.com/in/susanne-vogt-58744a1a5"
      },
      {
        "name": "Jeffrey P. Smith",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/jeffrey-smith-phd-7942601"
      },
      {
        "name": "Kathleen Ocasio",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/kathleenocasio"
      },
      {
        "name": "Joachim Maus",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/dr-joachim-maus-142b0"
      },
      {
        "name": "Kristina Marschall",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/kristina-dr-marschall-29660043"
      },
      {
        "name": "Matthew Hummel",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/matthew-hummel-29998982"
      },
      {
        "name": "Scott Haughie",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/scott-haughie-020a4b17"
      },
      {
        "name": "Abhijit Deshmukh",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/abhijit-deshmukh-057850301"
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-08-04",
    "source_url": "https://patents.google.com/patent/US12697341",
    "cpc_primary": {
      "code": "A61K 31/5415"
    },
    "patent_title": "Methods of using meloxicam for pain treatment and management",
    "patent_number": "US12697341",
    "uspto_assignee": "Viatris Inc.",
    "patent_abstract": "The present invention relates to a method for managing pain, such as acute pain, post-operative pain, or post-procedure pain, by administering meloxicam.",
    "precision_class": "structural",
    "invention_explanation": "A method of using meloxicam to relieve pain after an operation or other medical procedure, as well as sudden acute pain.",
    "technologies_mentioned": [
      "meloxicam",
      "pain management",
      "pharmaceutical treatment"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.